Cleared Traditional

K202860 - Valley Contax Single Vision (SV) Gas Permeable Contact Lens (roflufocon D, roflufocon E, tisilfocon A, hexafocon A, enflufocon A), Valley Contax Goldeneye Aspheric Front Multifocal (AFM) Gas Permeable Contact Lens (roflufocon D, roflufocon E, tisilfocon A, hexafocon A, enflufocon A), Valley Contax V Kone (VK) Gas Permeable Contact Lens (roflufocon D, roflufocon E, tisilfocon A, hexafocon A, enflufocon A) (FDA 510(k) Clearance)

May 2021
Decision
225d
Days
Class 2
Risk

K202860 is an FDA 510(k) clearance for the Valley Contax Single Vision (SV) Gas Permeable Contact Lens (roflufocon D, roflufocon E, tisilfocon A, hexafocon A, enflufocon A), Valley Contax Goldeneye Aspheric Front Multifocal (AFM) Gas Permeable Contact Lens (roflufocon D, roflufocon E, tisilfocon A, hexafocon A, enflufocon A), Valley Contax V Kone (VK) Gas Permeable Contact Lens (roflufocon D, roflufocon E, tisilfocon A, hexafocon A, enflufocon A). This device is classified as a Lens, Contact (other Material) - Daily (Class II - Special Controls, product code HQD).

Submitted by Valley Contax, Inc. (Springfield, US). The FDA issued a Cleared decision on May 11, 2021, 225 days after receiving the submission on September 28, 2020.

This device falls under the Ophthalmic FDA review panel. Regulated under 21 CFR 886.5916.

Submission Details

510(k) Number K202860 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 28, 2020
Decision Date May 11, 2021
Days to Decision 225 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF

Device Classification

Product Code HQD - Lens, Contact (other Material) - Daily
Device Class Class II - Special Controls
CFR Regulation 21 CFR 886.5916